Synthesis and evaluation of anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation properties of ibuprofen derivatives
In order to reduce the ulcerogenic effect of ibuprofen, its carboxylic group has been converted into 5-membered heterocyclic rings. Various 1,3,4-oxadiazoles (3-8, 16-21), 1,2,4-triazoles (22-27), 1,3,4-thiadiazoles (28-30), and 1,2,4-triazine (9) derivatives of ibuprofen were prepared by cyclization of 2-(4-i-butylphenyl) propionic acid hydrazide (2) and N1-[2-(4-i-butylphenyl) propionyl]-N4-alkyl/arylthiosemicarbazides (10-15) under various reaction conditions. The cyclized derivatives were screened for their anti-inflammatory activity by the carrageenan induced rat paw edema method and showed 50 to 86% inhibition, whereas the standard drug ibuprofen showed 92% inhibition at the same oral dose. Five compounds, 7, 16, 18, 22 and 30 that showed more than 80% anti-inflammatory activity were selected to study their analgesic, ulcerogenic and lipid peroxidation activities. All the tested compounds showed a significant reduction in ulcerogenic activity compared to ibuprofen through the severity index 0.5 to 0.8, vs. ibuprofen 1.8. The compounds, that showed less ulcerogenic effect also produced less malondialdehyde content in gastric mucosa, which is one of the end products of lipid peroxidation. The results of biological studies showed that oxadiazole derivative 16 as the lead molecule with maximum anti-inflammatory, analgesic and minimum ulcerogenic and lipid peroxidation activities.
M. B. Kimmey, NSAID, ulcers and prostaglandins, J. Rheumatol. 19 (1992) 68-73.
C. J. Smith, Y. Zhang, C. M. Koboldt, J. Muhammad, B. S. Zwefel, A. Shaffer, J. J. Talley, J. L. Masferrer, K. Serbert and P. C. Isakson, Pharmacological analysis of cyclo-oxygenase-1 in in-flammation, Proc. Natl. Acad. Sci. USA 95 (1998) 13313-13318.
C. Hawkey, L. Laine, T. Simon, A. Beaulieu, J. Maldonado-Cocco, E. Acevedo, A. Shahane, H. Quan, J. Bolognese and E. Mortensen, Comparison of the effect of rofecoxib, ibuprofen and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double blind, placebo-controlled trial, Arthritis Rheum. 43 (2000) 370-377.
T. D. Warner, F. Giuliano, I. Vaynovie, A. Bukasa, J. A. Mitchell and J. R. Vave, Non-steroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastro-intestinal toxicity: A full in vitro analysis, Proc. Natl. Acad. Sci. USA 96 (1999) 7563-7568.
F. L. Lanza, A guideline for the treatment and prevention of NSAID-induced ulcers, Am. J. Gastroenterol. 93 (1998) 2037-2046.
A. S. Kalgutkar, A. B. Marnett, B. C. Crews, R. P. Remmel and L. J. Marnett, Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclo-oxygenase-2 inhibitor, J. Med. Chem. 43 (2000) 2860-2870.
M. Duflos, M. R. Nourrisson, J. Brelet, J. Courant, G. Le Baut, N. Grimaud and J. Y. Petit, N-Pyridinyl-indole-3-(alkyl) carboxamides and derivatives as potential systemic and topical inflammation inhibitors, Eur. J. Med. Chem. 36 (2001) 545-553.
M. Amir and S. Kumar, Anti-inflammatory and gastro sparing activity of some new indomethacin derivatives, Arch. Pharm. Chem. Life Sci. 338 (2005) 24-31.
F. A. Omar, N. M. Mahfouz and M. A. Rahman, Design, synthesis and anti-inflammatory activity of some 1,3,4-oxadiazole derivatives, Eur. J. Med. Chem. 31 (1996) 819-825.
M. Amir, A. Oberoi and S. Alam, Synthesis and anti-inflammatory activity of some new 6-methoxy-β-methyl-2-naphthalene acetic acid derivatives, Indian J. Chem. 38B (1999) 237-239.
E. Palaska, G. Sahin, P. Kelicen, N. T. Durlu and G. Altinok, Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazide: 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones, Farmaco 57 (2002) 101-107.
B. Furniss, A. H. Hannaford, P. W. G. Smith and A. R. Tatchell, Vogel's Text Book of Practical Organic Chemistry, 5th ed., Addison Wesley Longman, New Delhi (1998 pp. 1077.
C. A. Winter, E. A. Risley and G. N. Nuss, Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs, Proc. Soc. Exp. Biol. 111 (1962) 544-547.
A. Kumar, D. Bansal, K. Bajaj, S. Sharma, Archana and V. K. Srivastava, Synthesis of some newer derivatives of 2-amino benzoic acid as potent anti-inflammatory and analgesic agents, Bioorg. Med. Chem. 11 (2003) 5281-5291.
V. Cioli, S. Putzolu, V. Rossi, P. Sorza Barcellona and C. Corradino, The role of direct tissue contact in the production of gastro-intestinal ulcers by anti-inflammatory drugs in rats, Toxicol. Appl. Pharmacol. 50 (1979) 283-289.
H. Ohkawa, N. Ohishi and K. Yagi, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Anal. Biochem. 95 (1979) 351-358.
B. Galunska, K. Marazova, T. Yankova, A. Popov, P. Frangov, I. Krushkov and D. I. Massa, Effect of paracetamol and propacetamol on gastric mucosal damage and gastric lipid per oxidation caused by acetylsalicylic acid in rats, Pharmacol. Res. 46 (2002) 141-148.
Y. Naito, T. Yoshikawa, N. Yoshida and M. Kondo, Role of oxygen radical and lipid peroxidation in indomethacin-induced gastric mucosal injury, Dig. Dis. Sci. 43 (Suppl. 9) (1998) 30S-34S.
T. Pohle, T. Brzozowski, J. C. Becker, I. R. Vander Voort, A. Markmann, S. J. Konturek, A. Moniczewski, W. Domschke and J. W. Konturek, Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans, gastroprotection by vitamin, Aliment. Pharmacol. Ther. 15 (2001) 677-687.